Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
Clinical trial NCT02245022 · COMPLETED
Trial details
- NCT number
- NCT02245022
- Sponsor
- University of Liverpool
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-14
- Primary completion
- 2018-12-06
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.